Widespread in vivo efficacy of The-0504: A conditionally-activatable nanoferritin for tumor-agnostic targeting of CD71-expressing cancers-Reference-Cited by-同舟云学术

Widespread in vivo efficacy of The-0504: A conditionally-activatable nanoferritin for tumor-agnostic targeting of CD71-expressing cancers

Published:2023-10 Issue:10 Volume:9 Page:e20770
ISSN:2405-8440
Container-title:Heliyon
language:en
Short-container-title:Heliyon

Author:

Fracasso Giulio^ORCID,Falvo Elisabetta,Tisci Giada^ORCID,Sala Gianluca^ORCID,Colotti Gianni^ORCID,Cingarlini Sara^ORCID,Tito Claudia,Bibbo Sandra^ORCID,Frusteri Cristina^ORCID,Tremante Elisa^ORCID,Giordani Elena^ORCID,Giacomini Patrizio^ORCID,Ceci Pierpaolo^ORCID

Funder

Associazione Italiana per la Ricerca sul Cancro

Airc Italian Foundation for Cancer Research

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference24 articles.

1. Natural products to prevent drug resistance in cancer chemotherapy: a review;Yuan;Ann. N. Y. Acad. Sci.,2017

2. Opinion: chemoprevention: an essential approach to controlling cancer;Sporn;Nat. Rev. Cancer,2002

3. The presence of glutamate residues on the PAS sequence of the stimuli-sensitive nano-ferritin improves in vivo biodistribution and mitoxantrone encapsulation homogeneity;Falvo;J. Contr. Release,2018

4. Improved Doxorubicin Encapsulation and Pharmacokinetics of Ferritin-Fusion Protein Nanocarriers Bearing Proline;Falvo,2016

5. Engineered human nanoferritin bearing the drug Genz-644282 for cancer therapy;Falvo;Pharmaceutics,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nose-to-brain selective drug delivery to glioma via ferritin-based nanovectors reduces tumor growth and improves survival rate;Cell Death & Disease;2024-04-13